Hungarian SME is looking for Turkish a manufacturing company of microRNA (Ribonucleic Acid) molecules and a university research group for joint Turkish-Hungarian bilateral grant application.

A Hungarian pharma/biotechnology R&D company is developing novel microRNA therapeutic compounds for ischemic diseases, e.g. ischemic cardiac disease, such as acute myocardial infarction and post-infarction heart failure. The company seeks partners to further develop the microRNA compounds in a joint Hungarian-Turkish grant application. Turkish partners needed: microRNA manufacturing company with preferably cGMP certification, and university research group with experience in microRNA research.
Participación en proyectos europeos de I+D
Enlace: Hungarian SME is looking for Turkish a manufacturing company of microRNA (Ribonucleic Acid) molecules and a university research group for joint Turkish-Hungarian bilateral grant application.